Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(40.0%)

Early Phase 1

2(40.0%)

Phase 4

1(20.0%)

5Total

N/A(2)

Early Phase 1(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05403125Early Phase 1Completed

SDF Application in Oral Cancer Patients to Prevent Dental Caries

Role: lead

NCT03929302Not ApplicableTerminated

Brain Energy Metabolism and Sleep in Adults

Role: collaborator

NCT03445286Not ApplicableCompleted

Silver Diamine Fluoride and Gingivitis in Geriatric Patients

Role: lead

NCT03254290Early Phase 1Unknown

Color Stability of NeoMTA Pulpotomized Primary Teeth

Role: lead

NCT02702505Phase 4Unknown

Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT

Role: lead

All 5 trials loaded